US Stock MarketDetailed Quotes

HRTX Heron Therapeutics

Watchlist
  • 1.740
  • -0.060-3.33%
Close Oct 31 16:00 ET
  • 1.780
  • +0.040+2.30%
Post 17:35 ET
263.90MMarket Cap-6960P/E (TTM)

Heron Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
83.05%-4.6M
61.78%-9.52M
59.98%-58.79M
106.54%2.46M
75.24%-9.18M
4.26%-27.17M
43.33%-24.9M
27.76%-146.91M
17.07%-37.53M
30.28%-37.07M
Net income from continuing operations
78.04%-9.24M
90.36%-3.16M
39.26%-110.56M
46.03%-10.72M
40.33%-25.01M
25.37%-42.06M
48.71%-32.77M
17.52%-182.02M
63.64%-19.87M
20.04%-41.91M
Operating gains losses
----
----
-86.49%10K
---13K
--0
----
----
-91.00%74K
--0
---22K
Depreciation and amortization
-13.26%641K
-4.04%689K
0.35%2.9M
-9.61%715K
2.97%727K
10.13%739K
-0.42%718K
-4.37%2.89M
-0.38%791K
-6.37%706K
Other non cash items
176.92%144K
174.51%140K
67.82%339K
226.00%163K
40.38%73K
4.00%52K
2.00%51K
-77.65%202K
0.00%50K
-24.64%52K
Change In working capital
-986.53%-3.42M
-1,811.36%-10.09M
259.81%16.79M
129.45%8.4M
224.00%8.53M
-97.71%386K
-106.59%-528K
70.05%-10.51M
-428.34%-28.53M
47.19%-6.88M
-Change in receivables
66.78%-8.39M
-962.73%-5.19M
51.13%-8.09M
137.10%3.66M
784.24%12.9M
-3,255.63%-25.25M
110.72%601K
-360.59%-16.55M
-229.97%-9.86M
-300.21%-1.89M
-Change in inventory
-105.26%-391K
-114.44%-363K
301.31%12.46M
95.59%-103K
-71.19%2.62M
253.38%7.44M
131.08%2.51M
4.42%-6.19M
66.08%-2.33M
599.46%9.08M
-Change in prepaid assets
-96.95%289K
-124.50%-222K
1,427.33%15.43M
203.58%4.89M
-89.43%172K
110.15%9.46M
323.70%906K
112.04%1.01M
-75.19%-4.72M
141.63%1.63M
-Change in payables and accrued expense
-41.98%5.07M
4.99%-4.32M
-126.82%-3.01M
99.67%-38K
54.42%-7.16M
-46.84%8.73M
-120.57%-4.55M
142.25%11.23M
-240.19%-11.61M
-57.93%-15.7M
Cash from discontinued investing activities
Operating cash flow
83.05%-4.6M
61.78%-9.52M
59.98%-58.79M
106.54%2.46M
75.24%-9.18M
4.26%-27.17M
43.33%-24.9M
27.76%-146.91M
17.07%-37.53M
30.28%-37.07M
Investing cash flow
Cash flow from continuing investing activities
-84.51%2.05M
-96.53%1.28M
641.37%18M
-537.21%-8.84M
35.58%-23.22M
-33.09%13.22M
236.51%36.83M
-110.16%-3.32M
108.33%2.02M
-266.62%-36.05M
Net PPE purchase and sale
-129.14%-637K
--0
4.13%-1.53M
42.34%-237K
-744.72%-793K
13.66%-278K
77.33%-224K
46.56%-1.6M
-14.80%-411K
108.03%123K
Net investment purchase and sale
-80.11%2.69M
-96.55%1.28M
1,231.34%19.53M
-453.58%-8.6M
37.99%-22.43M
-32.78%13.5M
210.52%37.06M
-104.83%-1.73M
110.18%2.43M
-256.14%-36.17M
Cash from discontinued investing activities
Investing cash flow
-84.51%2.05M
-96.53%1.28M
641.37%18M
-537.21%-8.84M
35.58%-23.22M
-33.09%13.22M
236.51%36.83M
-110.16%-3.32M
108.33%2.02M
-266.62%-36.05M
Financing cash flow
Cash flow from continuing financing activities
54.23%492K
105.29%11K
-27.91%54.11M
-54.67%199K
-28.22%53.8M
1.27%319K
67.35%-208K
-51.89%75.06M
-9.86%439K
105,652.11%74.94M
Net issuance payments of debt
----
----
--24.35M
--0
----
----
----
--0
--0
----
Net common stock issuance
----
----
-60.40%29.76M
--0
----
----
----
--75.15M
---18K
----
Proceeds from stock option exercised by employees
54.23%492K
105.29%11K
102.33%2K
-56.46%199K
-39.37%-308K
1.27%319K
67.35%-208K
-101.22%-86K
-6.16%457K
-325.00%-221K
Cash from discontinued financing activities
Financing cash flow
54.23%492K
105.29%11K
-27.91%54.11M
-54.67%199K
-28.22%53.8M
1.27%319K
67.35%-208K
-51.89%75.06M
-9.86%439K
105,652.11%74.94M
Net cash flow
Beginning cash position
-24.51%20.45M
86.65%28.68M
-83.03%15.36M
-30.89%34.86M
-72.31%13.46M
-52.40%27.09M
-83.03%15.36M
-13.88%90.54M
-68.39%50.44M
-74.57%48.61M
Current changes in cash
84.85%-2.06M
-170.16%-8.23M
117.71%13.31M
82.37%-6.18M
1,069.87%21.4M
-64.15%-13.63M
134.87%11.73M
-415.02%-75.18M
49.19%-35.07M
105.79%1.83M
End cash Position
36.58%18.39M
-24.51%20.45M
86.65%28.68M
86.65%28.68M
-30.89%34.86M
-72.31%13.46M
-52.40%27.09M
-83.03%15.36M
-83.03%15.36M
-68.39%50.44M
Free cash flow
80.90%-5.24M
62.12%-9.52M
59.44%-60.33M
105.81%2.21M
73.13%-9.97M
4.36%-27.44M
44.15%-25.12M
27.93%-148.74M
16.87%-37.95M
32.15%-37.11M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 83.05%-4.6M61.78%-9.52M59.98%-58.79M106.54%2.46M75.24%-9.18M4.26%-27.17M43.33%-24.9M27.76%-146.91M17.07%-37.53M30.28%-37.07M
Net income from continuing operations 78.04%-9.24M90.36%-3.16M39.26%-110.56M46.03%-10.72M40.33%-25.01M25.37%-42.06M48.71%-32.77M17.52%-182.02M63.64%-19.87M20.04%-41.91M
Operating gains losses ---------86.49%10K---13K--0---------91.00%74K--0---22K
Depreciation and amortization -13.26%641K-4.04%689K0.35%2.9M-9.61%715K2.97%727K10.13%739K-0.42%718K-4.37%2.89M-0.38%791K-6.37%706K
Other non cash items 176.92%144K174.51%140K67.82%339K226.00%163K40.38%73K4.00%52K2.00%51K-77.65%202K0.00%50K-24.64%52K
Change In working capital -986.53%-3.42M-1,811.36%-10.09M259.81%16.79M129.45%8.4M224.00%8.53M-97.71%386K-106.59%-528K70.05%-10.51M-428.34%-28.53M47.19%-6.88M
-Change in receivables 66.78%-8.39M-962.73%-5.19M51.13%-8.09M137.10%3.66M784.24%12.9M-3,255.63%-25.25M110.72%601K-360.59%-16.55M-229.97%-9.86M-300.21%-1.89M
-Change in inventory -105.26%-391K-114.44%-363K301.31%12.46M95.59%-103K-71.19%2.62M253.38%7.44M131.08%2.51M4.42%-6.19M66.08%-2.33M599.46%9.08M
-Change in prepaid assets -96.95%289K-124.50%-222K1,427.33%15.43M203.58%4.89M-89.43%172K110.15%9.46M323.70%906K112.04%1.01M-75.19%-4.72M141.63%1.63M
-Change in payables and accrued expense -41.98%5.07M4.99%-4.32M-126.82%-3.01M99.67%-38K54.42%-7.16M-46.84%8.73M-120.57%-4.55M142.25%11.23M-240.19%-11.61M-57.93%-15.7M
Cash from discontinued investing activities
Operating cash flow 83.05%-4.6M61.78%-9.52M59.98%-58.79M106.54%2.46M75.24%-9.18M4.26%-27.17M43.33%-24.9M27.76%-146.91M17.07%-37.53M30.28%-37.07M
Investing cash flow
Cash flow from continuing investing activities -84.51%2.05M-96.53%1.28M641.37%18M-537.21%-8.84M35.58%-23.22M-33.09%13.22M236.51%36.83M-110.16%-3.32M108.33%2.02M-266.62%-36.05M
Net PPE purchase and sale -129.14%-637K--04.13%-1.53M42.34%-237K-744.72%-793K13.66%-278K77.33%-224K46.56%-1.6M-14.80%-411K108.03%123K
Net investment purchase and sale -80.11%2.69M-96.55%1.28M1,231.34%19.53M-453.58%-8.6M37.99%-22.43M-32.78%13.5M210.52%37.06M-104.83%-1.73M110.18%2.43M-256.14%-36.17M
Cash from discontinued investing activities
Investing cash flow -84.51%2.05M-96.53%1.28M641.37%18M-537.21%-8.84M35.58%-23.22M-33.09%13.22M236.51%36.83M-110.16%-3.32M108.33%2.02M-266.62%-36.05M
Financing cash flow
Cash flow from continuing financing activities 54.23%492K105.29%11K-27.91%54.11M-54.67%199K-28.22%53.8M1.27%319K67.35%-208K-51.89%75.06M-9.86%439K105,652.11%74.94M
Net issuance payments of debt ----------24.35M--0--------------0--0----
Net common stock issuance ---------60.40%29.76M--0--------------75.15M---18K----
Proceeds from stock option exercised by employees 54.23%492K105.29%11K102.33%2K-56.46%199K-39.37%-308K1.27%319K67.35%-208K-101.22%-86K-6.16%457K-325.00%-221K
Cash from discontinued financing activities
Financing cash flow 54.23%492K105.29%11K-27.91%54.11M-54.67%199K-28.22%53.8M1.27%319K67.35%-208K-51.89%75.06M-9.86%439K105,652.11%74.94M
Net cash flow
Beginning cash position -24.51%20.45M86.65%28.68M-83.03%15.36M-30.89%34.86M-72.31%13.46M-52.40%27.09M-83.03%15.36M-13.88%90.54M-68.39%50.44M-74.57%48.61M
Current changes in cash 84.85%-2.06M-170.16%-8.23M117.71%13.31M82.37%-6.18M1,069.87%21.4M-64.15%-13.63M134.87%11.73M-415.02%-75.18M49.19%-35.07M105.79%1.83M
End cash Position 36.58%18.39M-24.51%20.45M86.65%28.68M86.65%28.68M-30.89%34.86M-72.31%13.46M-52.40%27.09M-83.03%15.36M-83.03%15.36M-68.39%50.44M
Free cash flow 80.90%-5.24M62.12%-9.52M59.44%-60.33M105.81%2.21M73.13%-9.97M4.36%-27.44M44.15%-25.12M27.93%-148.74M16.87%-37.95M32.15%-37.11M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ----Unqualified Opinion--------Unqualified Opinion----

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data